Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm?
- 1 July 1990
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 82 (1) , 188-195
- https://doi.org/10.1161/01.cir.82.1.188
Abstract
Endothelin-1 is an endothelium-derived vasoconstrictor peptide. Its circulating levels are below those known to evoke direct vascular effects. To study whether low concentrations of endothelin-1 potentiate the effects of other vasoconstrictor hormones, we suspended isolated human internal mammary and left anterior descending coronary artery rings in organ chambers for isometric tension recording. In mammary artery rings, the contractions to norepinephrine (3 x 10(-8) M) were potentiated by threshold (3 x 10(-10) M) and low concentrations (10(-9) M) of endothelin-1 (96 +/- 35% and 149 +/- 58% increase from control; p less than 0.01 and 0.001; n = 6). The inhibitor of endothelial nitric oxide formation L-NG-monomethyl arginine did not affect the potentiating effects of the peptide. The calcium antagonist darodipine (10(-7) M) prevented the potentiation of the response to norepinephrine evoked by endothelin-1. Similarly, contractions to serotonin (10(-7) or 3 x 10(-8) M) were amplified by endothelin-1 (3 x 1...This publication has 48 references indexed in Scilit:
- Endothelin enhances adrenergic vasoconstriction in perfused rat mesenteric arteriesBiochemical and Biophysical Research Communications, 1989
- Endothelin action on vascular smooth muscle involves inositol trisphosphate and calcium mobilizationBiochemical and Biophysical Research Communications, 1989
- Endothelin and Ca++ agonist bay K 8644: Different vasoconstrictive propertiesBiochemical and Biophysical Research Communications, 1988
- Difference between Endothelium-Dependent Relaxation in Arterial and in Venous Coronary Bypass GraftsNew England Journal of Medicine, 1988
- L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxationBiochemical and Biophysical Research Communications, 1988
- Platelet Activation in Unstable Coronary DiseaseNew England Journal of Medicine, 1986
- Coronary Spasm Producing Coronary Thrombosis and Myocardial InfarctionNew England Journal of Medicine, 1983
- Thromboxane A2in Vasotonic Angina PectorisNew England Journal of Medicine, 1981
- Release of Prostaglandins and Thromboxane into the Coronary Circulation in Patients with Ischemic Heart DiseaseNew England Journal of Medicine, 1981
- Coronary Vasospasm as a Possible Cause of Myocardial InfarctionNew England Journal of Medicine, 1978